The Tisch Cancer Institute
@TischCancer
Official account of The Tisch Cancer Institute @MountSinaiNYC. Committed to cancer prevention, detection, treatment & research. Appointments: 1-844-MD CANCER
ID:2546603755
http://www.tischcancerinstitute.org 04-06-2014 18:00:19
6,5K Tweets
3,8K Followers
987 Following
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses pubmed.ncbi.nlm.nih.gov/38653864/
Dmitriy Zamarin MD PhD and colleagues
We look forward to hearing from Linda Kachuri, PhD, on May 7: Using Polygenic Risk Scores for Cancer Detection and Risk Stratification.
Linda Kachuri Stanford Medicine
Hosted by Robert Klein, PhD Icahn School of Medicine at Mount Sinai
Join Deborah Doroshow and @nickrohsmd for #LungCancer summit, June 12.
Registration is open now.
event.onclive.com/X0My9Z?RefId=g…
OncLive.com Icahn School of Medicine at Mount Sinai
Join us May 21-23 at Mount Sinai Health System for Frontiers in Cancer Immunotherapy 2024, presented with The Tisch Cancer Institute & supported by @Pfizer. Hear from keynote speaker @CarlHJune of Penn on promising novel therapies & remaining challenges in the field. 🔬 Register: bit.nyas.org/3smWAyr
HealthTech Company Mika Announces Publication of Peer-Reviewed Clinical Trial apnews.com/press-release/…
Patients felt more empowered and motivated through the app, said Dr. Guy Montgomery, Director of the Center for Behavioral Oncology at Icahn School of Medicine at Mount Sinai
Today at #ONS2024 from Mount Sinai Health System:
What’s Your Superpower? Informatics at the Point of Care,
Toby Bressler, PhD, RN, OCN, FAAN
Learning Interventions to Improve Nurse Practitioners’ Knowledge and Confidence in Managing Complex Oncology Care Situations, Miwa Saito
Join us on Thursday, May 16, and Friday, May 17 for our short course, 'Introduction to Epidemiological Methods.' This hybrid event will be available via Zoom and in-person at Annenberg 10th floor. Register: bit.ly/4aUnRcV
#epimethods #researchmethods #ISMMS Institute for Translational Epidemiology
Decreasing Grade 3/4 Infections, Limited Hospitalizations Underscore Potential for Linvoseltamab in R/R Myeloma onclive.com/view/decreasin… via @onclive with Sundar Jagannath @icahnmountsinai
#MultipleMyeloma #linvoseltamab
Daily Aspirin May Help Boost the Immune System and Prevent Spread of Colorectal Cancer
health.com/aspirin-colore…
Peter Kozuch, MD, Icahn School of Medicine at Mount Sinai weighs in.
#colorectalcancer
What are the Treatment Options for Patients With Lenalidomide-Refractory Myeloma? bloodcancerstoday.com//post/what-are…
With Donna Catamero Mount Sinai Health System #MultipleMyeloma
Lung Cancer Cells Switch Oncogenic Drivers the-scientist.com/lung-cancer-ce…
Hideo Watanabe, MD, PhD Icahn School of Medicine at Mount Sinai weighs in. #lungcancer
We look forward to hearing from M. Raza Zaidi, PhD,
Fox Chase Cancer Center, on April 30.
'Illuminating the mechanisms of ultraviolet radiation-induced melanomagenesis'
Hosted by Jerry Edward Chipuk, PhD, Icahn School of Medicine at Mount Sinai
We look forward to hearing from Shawnna Buttery, PhD, Editor-in-Chief of Cell Reports, on May 21.
Dr. Shawnna Buttery 🔬
Hosted by Jerry Edward Chipuk, PhD, Icahn School of Medicine at Mount Sinai
Prostate Cancer Foundation Screening Guidelines for Black Men in the United States | NEJM Evidence evidence.nejm.org/doi/10.1056/EV…
From William Oh MD and colleagues #prostatecancer
Please join us
For a Multiple Myeloma RF and Icahn School of Medicine at Mount Sinai Patient Summit. The Tisch Cancer Institute. #mmsm
Saturday, May 4, 2024
8:00 AM–12:30 PM (ET) event.webcasts.com/viewer/share.j…
Congratulations to Miriam Merad, MD, PhD, appointed as Dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai.
Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai #Immunology #Immunotherapy
